ArticleTheranostics2021

NEK9, a novel effector of IL-6/STAT3, regulates metastasis of gastric cancer by targeting ARHGEF2 phosphorylation.

Guofang Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.